Published August 2, 2026
The Missouri state court overseeing Bayer's proposed $7.25 billion Roundup class settlement has set a new final approval hearing date of August 19, 2026. The delay follows a July fairness hearing where more than 100 objections were raised over the settlement's opt-out process, attorney fees, and a novel subclass covering people exposed to Roundup who haven't yet developed cancer.
The rescheduling means the roughly two-thirds of pending Roundup claims Bayer has already resolved — along with the framework meant to cover remaining and future claims — still don't have a legally final settlement in place, even as the underlying legal landscape has been shifting in Bayer's favor on a separate front.
On June 25, 2026, the U.S. Supreme Court ruled 7-2 in Monsanto Co. v. Durnell that federal pesticide law preempts state-level failure-to-warn claims requiring a cancer warning the EPA hasn't approved — reversing a jury verdict Bayer had lost on that theory. That ruling doesn't eliminate the roughly 65,000 remaining Roundup claims, since most plaintiffs also raise negligence, misrepresentation, and design-defect theories that survive the preemption ruling. But it does remove one of the strongest legal arguments plaintiffs had been relying on, which legal commentators say strengthens Bayer's negotiating position heading into the August 19 hearing.
At a related July 2026 status conference, Bayer signaled it will argue the federal MDL itself should be dismantled in light of the Supreme Court's ruling — a separate fight from the Missouri state court settlement, but one that could shape how much leverage plaintiffs' attorneys have in pushing back on the settlement's terms.
Until the settlement receives final approval, existing objections remain unresolved and the exact terms available to claimants aren't locked in. The federal MDL is also still accepting new claims. See Atumio's Roundup lawsuit page for a free eligibility review, or start your case review directly.